AI is revolutionizing drug and therapeutics discovery, but the supervised learning approaches that have dominated up to now — which depend on data labeled by human experts — aren’t scalable. Noetik is generating the hundreds of terabytes of genomic, transcriptomic, and proteomic data on cells and tissues that will be needed to power self-supervised, transformer-based predictive modeling in the realm of cancer immunotherapy. The company’s platform helps identify novel targets for therapeutics and predicts how patients will respond.
In The Media
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules
Using synthetic biology to manufacture carbon-negative materials
Combining systems pharmacology and AI to accelerate drug discovery